CADTH | Search

Current Filters

Showing 1 - 10 results of 3579

Adalimumab (Humira) (Last Updated: Sep 24, 2004)

Project Line:
Reimbursement Review
Project Status:
Complete
Contains:
Brand Name Manufacturer Submission Type Indications

Brand Name:
Humira
Manufacturer:
Abbott Laboratories Limited
Submission Type:
Initial
Indications:

Arthritis, Rheumatoid

Eletriptan hydrobromide (Relpax) (Last Updated: Sep 21, 2004)

Project Line:
Reimbursement Review
Project Status:
Complete
Contains:
Brand Name Manufacturer Submission Type Indications

Brand Name:
Relpax
Manufacturer:
Pfizer Canada Inc.
Submission Type:
Initial
Indications:

Migraine

Voriconazole (VFEND) (Last Updated: Aug 24, 2004)

Project Line:
Reimbursement Review
Project Status:
Withdrawn
Contains:
Brand Name Manufacturer Submission Type Indications

Brand Name:
VFEND
Manufacturer:
Pfizer Canada Inc.
Submission Type:
Initial
Indications:

Aspergillosis, Invasive

Dutasteride (Avodart) (Last Updated: Aug 24, 2004)

Project Line:
Reimbursement Review
Project Status:
Complete
Contains:
Brand Name Manufacturer Submission Type Indications

Brand Name:
Avodart
Manufacturer:
GlaxoSmithKline Inc.
Submission Type:
Initial
Indications:

Prostatic hyperplasia, benign

Cinacalcet hydrochloride (Sensipar) (Last Updated: Aug 20, 2004)

Project Line:
Reimbursement Review
Project Status:
Complete
Contains:
Brand Name Manufacturer Submission Type Indications

Brand Name:
Sensipar
Manufacturer:
Amgen Canada Inc.
Submission Type:
Initial
Indications:

Secondary hyper-parathyroidism in chronic kidney disease

Butoconazole nitrate (Gynazole.1) (Last Updated: Jun 30, 2004)

Project Line:
Reimbursement Review
Project Status:
Complete
Contains:
Brand Name Manufacturer Submission Type Indications

Brand Name:
Gynazole.1
Manufacturer:
Ferring Pharmaceuticals
Submission Type:
Initial
Indications:

Vaginal infection

Eprosartan mesylate/ hydrochlorothiazide (Teveten Plus) (Last Updated: Jul 8, 2004)

Project Line:
Reimbursement Review
Project Status:
Complete
Contains:
Brand Name Manufacturer Submission Type Indications

Brand Name:
Teveten Plus
Manufacturer:
Solvay Pharma Inc.
Submission Type:
Initial
Indications:

Hypertension, Essential

Teriparatide (rDNA origin) injection (Forteo) (Last Updated: Jun 8, 2004)

Project Line:
Reimbursement Review
Project Status:
Complete
Contains:
Brand Name Manufacturer Submission Type Indications

Brand Name:
Forteo
Manufacturer:
Eli Lilly Canada Inc.
Submission Type:
Initial
Indications:

Osteoporosis

Ciprofloxacin hydrochloride and dexamethasone otic suspension (Ciprodex) (Last Updated: Jun 11, 2004)

Project Line:
Reimbursement Review
Project Status:
Complete
Contains:
Brand Name Manufacturer Submission Type Indications

Brand Name:
Ciprodex
Manufacturer:
Alcon Canada Inc.
Submission Type:
Initial
Indications:

Otitis media with otorrhea & otitis externa, acute

Peginterferon alfa-2a and Ribavirin (Pegasys RBV) (Last Updated: May 14, 2004)

Project Line:
Reimbursement Review
Project Status:
Complete
Contains:
Brand Name Manufacturer Submission Type Indications

Brand Name:
Pegasys RBV
Manufacturer:
Hoffman-La Roche Ltd.
Submission Type:
Initial
Indications:

Hepatitis C, chronic

Download results as CSV